Search

everythinglearnresearchcommunity

for

Search:↓

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Finasteride crystals are held together by hydrogen bonds and weak interactions, forming synthon pseudopolymorphs.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Indole-based compounds improved ovarian health in rats with PCOS, with L-Tryptophan and Tryptophol being most effective.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Some dibenzo compounds might help treat cancer with fewer side effects.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

CoCr2O4 catalysts effectively and sustainably produce diaminopyrimidine oxides with high yield.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.